Immediate Impact
22 standout
Citing Papers
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
2024 Standout
Multiple myeloma
2024 Standout
Works of Andrew Trigg being referenced
Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m2 vs. twice-weekly 27 mg/m2 carfilzomib (randomized A.R.R.O.W. study)
2019
Estimation of minimally important differences and responder definitions for EORTC QLQ‐MY20 scores in multiple myeloma patients
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Andrew Trigg | 47 | 25 | 71 | 46 | 40 | 321 | |
| F.S. Mennini | 39 | 12 | 27 | 31 | 43 | 328 | |
| Jonathan Gravel | 17 | 10 | 27 | 40 | 19 | 328 | |
| Sheila R. Reddy | 58 | 37 | 73 | 57 | 29 | 354 | |
| Santo Longo | 48 | 16 | 48 | 9 | 49 | 322 | |
| Harold E. Nelson | 13 | 10 | 58 | 25 | 24 | 312 | |
| Erin Stevens | 12 | 26 | 104 | 47 | 43 | 369 | |
| Fuad Ismail | 23 | 25 | 90 | 14 | 31 | 328 | |
| Daniel Redondo‐Sánchez | 50 | 28 | 152 | 23 | 28 | 364 | |
| Rabia Malik | 9 | 26 | 30 | 42 | 28 | 305 | |
| Kathleen Klein | 36 | 18 | 48 | 7 | 31 | 340 |
All Works
Login with ORCID to disown or claim papers
Loading papers...